To respond to the legitimate questions raised by the application of invasive methods of monitoring and life-support techniques in cancer patients admitted in the ICU, the European Lung Cancer Working Party and the Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique, set up a consensus conference. The methodology involved a systematic literature review, experts’ opinion and a final consensus conference about nine predefined questions

1. Which triage criteria, in terms of complications and considering the underlying neoplastic disease and possible therapeutic limitations, should be used to guide admission of cancer patient to intensive care units?

2. Which ventilatory support [High Flow Oxygenation, Non-invasive Ventilation (NIV), Invasive Mechanical Ventilation (IMV), Extra-Corporeal Membrane Oxygenation (ECMO)] should be used, for which complications and in which environment?

3. Which support should be used for extra-renal purification, in which conditions and environment?

4. Which haemodynamic support should be used, for which complications, and in which environment?

5. Which benefit of cardiopulmonary resuscitation in cancer patients and for which complications?

6. Which intensive monitoring in the context of oncologic treatment (surgery, anti-cancer treatment …)?

7. What specific considerations should be taken into account in the intensive care unit?

8. Based on which criteria, in terms of benefit and complications and taking into account the neoplastic disease, patients hospitalized in an intensive care unit (or equivalent) should receive cellular elements derived from the blood (red blood cells, white blood cells and platelets)?

9. Which training is required for critical care doctors in charge of cancer patients?

为了回应在 ICU 入院的癌症患者中应用侵入性监测和生命支持技术所提出的合理问题，欧洲肺癌工作组和 Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique 达成共识会议。该方法涉及系统文献回顾、专家意见和关于九个预定义问题的最终共识会议

1. 哪些分诊标准，在并发症方面，考虑到潜在的肿瘤疾病和可能的治疗限制，应该用于指导癌症患者进入重症监护室？

2. 应该使用哪种通气支持[高流量氧合、无创通气 (NIV)、有创机械通气 (IMV)、体外膜氧合 (ECMO)]，针对哪些并发症以及在何种环境下使用？

3. 肾外净化应该使用哪种支架，在什么条件和环境下使用？

4. 应该使用哪种血流动力学支持、针对哪些并发症以及在哪种环境中使用？

5. 对癌症患者进行心肺复苏有哪些益处以及哪些并发症？

6. 在肿瘤治疗（手术、抗癌治疗……）的背景下进行哪些强化监测？

7. 在重症监护病房应考虑哪些具体因素？

8. 根据哪些标准，在益处和并发症方面并考虑到肿瘤疾病，在重症监护室（或同等机构）住院的患者应接受来自血液的细胞成分（红细胞、白细胞和血小板） )?

9. 负责癌症患者的重症监护医生需要哪些培训？